Amalia Dolga receives funding from Michael J. Fox Foundation
Parkinson’s disease (PD) is an incurable disease and the second most common neurodegenerative disease, affecting millions of people globally. Degeneration of the neuronal network leads to miscommunication between dopaminergic cells located in various brain regions involved in motor coordination. The transport of mitochondria from one cell to another is critical for maintaining cell function and survival. Transferring healthy mitochondria to another cell in which mitochondrial function is impaired may be a way to reverse the effects of neurodegeneration. Prof. Amalia Dolga of the Groningen Research Institute of Pharmacy (GRIP) received $500,000 funding from the Michael J. Fox Foundation to study these aspects in Parkinson’s disease. These studies will serve as a starting point for the development of new therapies that target mitochondrial dysfunction.
Last modified: | 15 June 2023 4.23 p.m. |
More news
-
16 September 2025
The ocean absorbs carbon from the air, but what if the temperature increases?
‘Fortunately, seawater absorbs carbon dioxide (CO₂). If it didn’t, things would have been over and done with already,’ according to climate and ocean researchers Richard Bintanja and Rob Middag. But what actually happens to the ocean's carbon...
-
10 September 2025
Funding for Feringa and Minnaard from National Growth Fund project Big Chemistry
Two UG research projects have received funding from the National Growth Fund project Big Chemistry via NWO.
-
09 September 2025
Carbon dioxide’s fingerprint
In the year 2000, Harro Meijer, Professor of Isotope Physics at the University of Groningen, set up the Lutjewad Measurement Station near Hornhuizen. There, researchers from Groningen are mapping where CO2 in the atmosphere originates and where it...